168 related articles for article (PubMed ID: 37504352)
21. Sarcomatoid carcinoma in head and neck: a review of 30 years of experience--clinical outcomes and reconstructive results.
Chang NJ; Kao DS; Lee LY; Chang JW; Hou MM; Lam WL; Cheng MH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S1-7. PubMed ID: 24284734
[TBL] [Abstract][Full Text] [Related]
22. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
23. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
24. Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients.
Benasso M; Bonelli L; Numico G; Corvò R; Sanguineti G; Rosso R; Vitale V; Merlano M
Ann Oncol; 1997 Aug; 8(8):773-9. PubMed ID: 9332685
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
26. Case series report: radiation-induced oropharyngeal carcinoma.
Salman S; Doweck I; Taha T; Billan S
Anticancer Drugs; 2023 Feb; 34(2):325-331. PubMed ID: 36730617
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma.
Prieto-Granada CN; Xu B; Alzumaili B; Al Rasheed MRH; Eskander A; Enepekides D; Patel SG; Stevens TM; Dogan S; Ghossein R; Katabi N
Virchows Arch; 2021 Oct; 479(4):729-739. PubMed ID: 33982148
[TBL] [Abstract][Full Text] [Related]
28. Synchronous bilateral tonsillar squamous cell carcinoma related to human papillomavirus: Two case reports and a brief review of the literature.
Rasband-Lindquist A; Shnayder Y; O'Neil M
Ear Nose Throat J; 2016; 95(4-5):E30-4. PubMed ID: 27140027
[TBL] [Abstract][Full Text] [Related]
29. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
Toda K; Shibuya H; Hayashi K; Ayukawa F
Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
[TBL] [Abstract][Full Text] [Related]
31. "MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report".
Yabe TE; King K; Russell S; Satgunaseelan L; Gupta R; Chen J; Ashford B
Diagn Pathol; 2022 Feb; 17(1):23. PubMed ID: 35125114
[TBL] [Abstract][Full Text] [Related]
32. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
[TBL] [Abstract][Full Text] [Related]
33. Outcomes and Prognostic Factors of Radiation-Induced and De Novo Head and Neck Squamous Cell Carcinomas.
Tay GC; Iyer NG; Ong WS; Tai D; Ang MK; Ha TC; Soo KC; Tan HK
Otolaryngol Head Neck Surg; 2016 May; 154(5):880-7. PubMed ID: 26956200
[TBL] [Abstract][Full Text] [Related]
34. A case of peritoneal metastasis during treatment for hypopharyngeal squamous cell carcinoma.
Wakasaki T; Omori H; Sueyoshi S; Rikimaru F; Toh S; Taguchi K; Higaki Y; Morita M; Masuda M
World J Surg Oncol; 2016 Oct; 14(1):265. PubMed ID: 27756320
[TBL] [Abstract][Full Text] [Related]
35. Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma.
DE Felice F; Musio D; Serpone M; Vavalle G; Marchetti C; Tombolini V
Anticancer Res; 2022 Dec; 42(12):5909-5915. PubMed ID: 36456162
[TBL] [Abstract][Full Text] [Related]
36. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
38. The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?
Reis Ferreira M; Pasto A; Ng T; Patel V; Guerrero Urbano T; Sears C; Wade WG
Cancer Treat Rev; 2022 Sep; 109():102442. PubMed ID: 35932549
[TBL] [Abstract][Full Text] [Related]
39. Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma.
Kim AJ; Suh JD; Sercarz JA; Abemayor E; Head C; Funk G; Blackwell KE
Laryngoscope; 2007 Jun; 117(6):1019-23. PubMed ID: 17545864
[TBL] [Abstract][Full Text] [Related]
40. Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
Belgioia L; Becherini C; Bacigalupo A; Bonomo P
Oral Oncol; 2022 Apr; 127():105773. PubMed ID: 35217401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
